Login
Existing Account

Please login first to complete purchase/ quotation request, view custom order reports, or create favorites list.

Customer ID:
Password:
Stay Logged In


Forgot your Customer ID or Password?
New Account

Don't have an account with us yet? Please set up an account to place order or obtain customer services.

Peptides  >  Amyloid Peptides  >  Beta-Amyloid (1-42) and Related Peptides  >>  Beta-Amyloid (1-42), HiLyte™ Fluor 488-labeled, Human

Product Name Beta - Amyloid (1 - 42), HiLyte™ Fluor 488 - labeled, Human
HiLyte™ Fluor 488 - DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA
Size 0.1 mg
Catalog # 60479-01
US$ $237
Purity % Peak Area By HPLC ≥ 95%
Description

This is a fluorescent (HiLyte™ Fluor 488)-labeled ß-Amyloid peptide, Abs/Em=503/528 nm. Hilyte 488™ Fluor labeled Aß (1-42) has a brighter intensity than FAM-labeled Aß (1-42).

Fgure 1. Absoprtion and emission spectra of HiLyte™ Fluor 488 labeled β-Amyloid (1-42).

Figure 2. Staining pattern of HiLyte™ Fluor 488 labeled Aβ (1-42) peptide on an AD (A) and a normal brain (B). Images courtesy of Dr. Jian-Ping Guo in Dr. Patrick L. McGeer’s lab, University of British Columbia, Vancouver, Canada.

Images Beta-Amyloid (1-42), HiLyte™ Fluor 488-labeled, Human
Detailed Information Datasheet
Material Safety Data Sheets (MSDS)
Brochure
Storage -20°C
Molecular Weight 4870.5
Sequence
(One-Letter Code)
HiLyte™ Fluor 488-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA
Sequence
(Three-Letter Code)
Hilyte™ Fluor488 - Asp - Ala - Glu - Phe - Arg - His - Asp - Ser - Gly - Tyr - Glu - Val - His - His - Gln - Lys - Leu - Val - Phe - Phe - Ala - Glu - Asp - Val - Gly - Ser - Asn - Lys - Gly - Ala - Ile - Ile - Gly - Leu - Met - Val - Gly - Gly - Val - Val - Ile - Ala - OH
Product Citations Esbjörner, EK. et al. (2014). Direct Observations of Amyloid β Self-Assembly in Live Cells Provide Insights into Differences in the Kinetics of Aβ (1–40) and Aβ (1–42) Aggregation. Chem Biol 21, 732. doi: 10.1016/j.chembiol.2014.03.014.
Mittag, JJ. et al. (2014). Simultaneous measurement of a range of particle sizes during Aβ< sub> 1–42 fibrillogenesis quantified using fluorescence correlation spectroscopy. Biochem Biophys Res Comm 448, 195. doi: 10.1016/j.bbrc.2014.04.088.
Narayan, P. et al. (2014). Rare Individual Amyloid-β Oligomers Act on Astrocytes to Initiate Neuronal Damage. Biochem 53, 2442. doi: 10.1021/bi401606f.
Saresella, M. et al. (2014). A Complex Proinflammatory Role for Peripheral Monocytes in Alzheimer's Disease. J Alzheimers Dis 38, 403.
Tian, L. et al. (2014). Decreased Expression of Cathepsin D in Monocytes is Related to the Defective Degradation of Amyloid-β in Alzheimer's Disease. J Alzheimers Dis. Doi: 10.3233/JAD-132192.
Tiribuzi, R. et al. (2014). miR128 up-regulation correlates with impaired amyloid β (1-42) degradation in monocytes from patients with sporadic Alzheimer's disease. Neurobiol Aging 35, 345.
Frenkel, D. et al. (2013). Scara1 deficiency impairs clearance of soluble amyloid-β by mononuclear phagocytes and accelerates Alzheimer’s-like disease progression. Nature Commun doi: 10.1038/ncomms3030.
Li, W. et al. (2013). Autophagy is involved in oligodendroglial precursor-mediated clearance of amyloid peptide. Mol Neurodegener 8, 27.
Zhu, L. et al. (2013). Reduction of synaptojanin 1 accelerates Aβ clearance and attenuates cognitive deterioration in an Alzheimer mouse model. J Biol Chem 288, 32050. doi: 10.1074/jbc.M113.504365.
Adolfsson, O. et al. (2012). An effector-reduced anti-β-amyloid (Aβ) antibody with unique Aβ binding properties promotes neuroprotection and glial engulfment of Aβ. J Neurosci 32, 9677.
Le Droumaguet, B. et al. (2011). Selegiline-functionalized, PEGylated poly(alkyl cyanoacrylate) nanoparticles: Investigation of interaction with amyloid-β peptide and surface reorganization. Int J Pharm doi:10.1016/j.ijpharm.2011.01.015.
Chakrabarty, P. et al. (2010). Massive gliosis induced by interleukin-6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J 24, 548.
Guo, J-P. et al. (2010). Simple in vitro assays to identify amyloid-β aggregation blockers for Alzheimer's disease therapy. J Alzheimer's Dis 19, 1359.
Halle, A. et al. (2008). The NALP3 inflammasome is involved in the innate immune response to amyloid-bold beta. Nature Immunol 9, 857.
Hickman, S. et all (2008). Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer's Disease mice. J. Neurosci. 28, 8354.
Nazer, B. et al. (2008). LRP promotes endocytosis and degradation, but not transcytosis, of the amyloid-β peptide in a blood–brain barrier in vitro model. Neurobio. Dis. 30, 94.
Vestergaard, M. et al. (2008). Detection of Alzheimer’s amyloid beta aggregation by capturing molecular trails of individual assemblies. Biochem. Biophys. Res. Comm. 377, 725.
Widenbrant, M. J. O. et al. (2006). Lipid-Induced β-Amyloid Peptide Assemblage Fragmentati. Biophys. J. 91, 4071.
     
  < Back